Thermo Scientific Auto Trace 280 Solid Phase Extraction (SPE) System or Equivalent
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | SBA Certified Women-Owned Small Business (WOSB) Program Set-Aside (FAR 19.15) |
| Posted Date: | Aug 29, 2025 |
| Due Date: | Sep 4, 2025 |
| Solicitation No: | 75F40125Q00404 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Aug 29, 2025 03:11 pm EDT
- Original Date Offers Due: Sep 04, 2025 01:00 pm EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Sep 19, 2025
-
Initiative:
- None
- Original Set Aside: SBA Certified Women-Owned Small Business (WOSB) Program Set-Aside (FAR 19.15)
- Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
-
Place of Performance:
The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research – St. Louis (OPQR–St. Louis), requires the acquisition of a Thermo Scientific AutoTrace 280 Solid Phase Extraction (SPE) System or equivalent, including delivery, installation, qualification (IQ/OQ), training, and warranty. The system will support the FDA’s nitrosamine testing program by automating pre-concentration of contaminants such as NDBA, NDMA, NMOR, and NDEA from large-volume intravenous (IV) drug products to ensure reproducible and accurate results.
Interested vendors are advised to carefully read the attached Combined Synopsis/Solicitation (CSS 75F40125Q00404) in its entirety for full details, submission instructions, and applicable provisions/clauses.
Questions are due no later than September 2, 2025, at 10:30 AM Eastern Time (ET).
Quotations are due no later than September 4, 2025, at 4:00 PM Eastern Time (ET).
- 4041 Powder Mill Road 4th Floor
- Beltsville , MD 20705
- USA
- Iris Johnson
- Iris.Johnson1@fda.hhs.gov
- Phone Number 3017963353
- Aug 29, 2025 03:11 pm EDTCombined Synopsis/Solicitation (Original)
See Also
Follow 66--CONTROL-DISPLAY UNI, IN REPAIR/MODIFICATION OF Active Contract Opportunity Notice ID N0038326QNB22 Related
DEPT OF DEFENSE
Due by 10/26/2026
Follow INDICATOR,COURSE Active Contract Opportunity Notice ID SPRMM126QMJ06 Related Notice Department/Ind. Agency DEPT
DEPT OF DEFENSE
Due by 10/09/2026
Follow 66--CONTROL-DISPLAY UNI, IN REPAIR/MODIFICATION OF Active Contract Opportunity Notice ID N0038326QNB24 Related
DEPT OF DEFENSE
Due by 10/26/2026
Follow 66--GENERATOR,TIME CODE Active Contract Opportunity Notice ID N0038326QTC88 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Due by 10/13/2026